AU2002304743A1 - Cancer treatment by using fap-alpha specific antibodies - Google Patents

Cancer treatment by using fap-alpha specific antibodies

Info

Publication number
AU2002304743A1
AU2002304743A1 AU2002304743A AU2002304743A AU2002304743A1 AU 2002304743 A1 AU2002304743 A1 AU 2002304743A1 AU 2002304743 A AU2002304743 A AU 2002304743A AU 2002304743 A AU2002304743 A AU 2002304743A AU 2002304743 A1 AU2002304743 A1 AU 2002304743A1
Authority
AU
Australia
Prior art keywords
fap
specific antibodies
cancer treatment
alpha specific
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002304743A
Inventor
Andree Amelsberg
Andrew Scott
Paul Tanswell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim International GmbH
Publication of AU2002304743A1 publication Critical patent/AU2002304743A1/en
Abandoned legal-status Critical Current

Links

AU2002304743A 2001-04-12 2002-04-11 Cancer treatment by using fap-alpha specific antibodies Abandoned AU2002304743A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/283,868 2001-04-12

Publications (1)

Publication Number Publication Date
AU2002304743A1 true AU2002304743A1 (en) 2002-10-28

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AUPR395801A0 (en) Antibodies against cancer
AU2002360766A1 (en) Methods for cancer imaging
EP1572131A4 (en) Antibody therapy
AU2001282717A1 (en) Cancer treatment by combination therapy
AU2002366877A1 (en) Using touchscreen by pointing means
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AUPS054702A0 (en) Cancer therapy
AU2003224076A1 (en) Antibody combination useful for tumor therapy
AU2002226650A1 (en) Redox therapy for tumors
AU2002365649A1 (en) Anti-dota antibody
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002349543A1 (en) Tumor antigens
AU2002351374A1 (en) Antibodies to treat cancer
AU2003302822A1 (en) Antibodies to treat cancer
AU2002353739A1 (en) Therapeutic compounds
AU2002308642A1 (en) Methods for treating cancer
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003222449A1 (en) Medicine for treating cancer
AU2002335667A1 (en) Modified reoviral therapy
AU2003277832A1 (en) Humanized tissue factor antibodies
AU2001257325A1 (en) Cancer treatment
AU2003283339A1 (en) Cancer therapy determination
AU2002304743A1 (en) Cancer treatment by using fap-alpha specific antibodies
AU2002351382A1 (en) Combination cancer therapy